Welcome

Printer-friendly

MTZ Clinical Research Sp. z o.o. is the leading Polish company specialized in conducting early phases clinical trials, bioequivalence and bioavailability studies. The company has been operating since 2002, conducting studies for European and American pharmaceutical and biopharmaceutical companies and CROs (Contract Research Organizations).
The majority of studies is conducted at own clinical research site, designed for up to 30 subjects. In addition to that, the company conducts single and multicentre trials (Phase II) at specialized clinics across Poland. The clinical research site is also used as specialized site in Phase III studies.

Since August 2009 MTZ Clinical Research holds ISO 9001:2008 Certificate (UKAS Quality Management) for two areas of research:

• Conduct of contracted clinical trials
• Operation of MTZ Clinical Research Site 

MTZ has conducted over 90 research projects with over 5000 participating healthy subjects and patients. Subjects  are recruited from our own registered database of volunteers. Over 6000 healthy volunteers and patients are registered there, both smokers and non-smokers at the age range of 18-75 years.

The company head office and clinical research site are located in the "Ochota" Campus atInstitute of Experimental and Clinical Medicine of the Polish Academy of Sciences near  Public Central Teaching Hospital and Warsaw Medical University (Warsaw, Poland).